Unknown

Dataset Information

0

BIRC5 Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas.


ABSTRACT: Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) are the most common types of cancers in the head and neck region (HNSCC). Despite very aggressive treatment modalities, the five-year survival rate has not changed for decades and is still around 60%. The search for potential specific biomarkers of aggressiveness or outcome indicators could be of great benefit in improving the treatment of these patients. One of the potential biomarkers is survivin, the protein product of the BIRC5 gene. In this study, we investigated the occurrence of BIRC5 gene polymorphisms in 48 patients with OSCC and OPSCC compared with healthy controls. A total of 18 polymorphisms were found, 11 of which occurred in HNSCC with a minor allele frequency (MAF) of more than 5%. Five polymorphisms (rs3764383, rs9904341, rs2071214, rs2239680, rs2661694) were significantly associated with tumor size, tumor stage, and advanced regional disease, but had no impact on survival.

SUBMITTER: Mumlek I 

PROVIDER: S-EPMC10743484 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>BIRC5</i> Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas.

Mumlek Ivan I   Ozretić Petar P   Sabol Maja M   Leović Matko M   Glavaš-Obrovac Ljubica L   Leović Dinko D   Musani Vesna V  

International journal of molecular sciences 20231214 24


Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) are the most common types of cancers in the head and neck region (HNSCC). Despite very aggressive treatment modalities, the five-year survival rate has not changed for decades and is still around 60%. The search for potential specific biomarkers of aggressiveness or outcome indicators could be of great benefit in improving the treatment of these patients. One of the potential biomarkers is survivin, the protein  ...[more]

Similar Datasets

| S-EPMC5481414 | biostudies-literature
| S-EPMC6258135 | biostudies-literature
| S-EPMC8024082 | biostudies-literature
| S-EPMC6481346 | biostudies-literature
| S-EPMC3668826 | biostudies-literature
| S-EPMC3734385 | biostudies-literature
2013-09-16 | GSE41152 | GEO
| S-EPMC9641857 | biostudies-literature
| S-EPMC7386373 | biostudies-literature
| S-EPMC4836998 | biostudies-literature